Clinical Evaluation Of GW815SF For Chronic Obstructive Pulmonary Disease (Chronic Bronchitis, Emphysema)
Status:
Completed
Trial end date:
2005-08-01
Target enrollment:
Participant gender:
Summary
This study compares the effect of two medicines on COPD (Chronic Obstructive Pulmonary
Disease). This study will last up to 18 weeks, and subjects will visit the clinic 5 times.
Subjects will be given breathing tests, and will record their breathing symptoms daily on
diary cards.
Phase:
Phase 3
Details
Lead Sponsor:
GlaxoSmithKline
Treatments:
Fluticasone Fluticasone Propionate, Salmeterol Xinafoate Drug Combination Fluticasone-Salmeterol Drug Combination Salmeterol Xinafoate Xhance